Double-Stranded RNA—Dependent Protein Kinase Is Not Required for Double-Stranded RNA—Induced Nitric Oxide Synthase Expression or Nuclear Factor-κB Activation by Islets
- From the Edward A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, Missouri.
- Address correspondence and reprint requests to Dr. John A. Corbett, St. Louis University School of Medicine, Department of Biochemistry and Molecular Biology, 1402 South Grand Blvd., St. Louis, MO 63104. E-mail: corbettj{at}slu.edu .
Abstract
Environmental factors, such as viral infection, have been implicated in the destruction of β-cells during the development of autoimmune diabetes. Double-stranded RNA (dsRNA), produced during viral replication, is an active component of a viral infection that stimulates antiviral responses in infected cells. Previous studies have shown that treatment of rat islets with dsRNA in combination with γ-interferon (IFN-γ) results in a nitric oxide-dependent inhibition of glucose-stimulated insulin secretion. This study examines the role of nuclear factor-κB (NF-κB) and the dsRNA-dependent protein kinase (PKR) in dsRNA + IFN-γ-induced nitric oxide synthase (iNOS) expression and nitric oxide production by rat, mouse, and human islets. Treatment of rat and human islets with dsRNA in the form of polyinosinic-polycytidylic acid (poly IC) and IFN-γ resulted in iNOS expression and nitric oxide production. Inhibitors of NF-κB activation—the proteasome inhibitor MG-132 and the antioxidant pyrrolidinedithiocarbamate (PDTC)—prevented poly IC + IFN-γ-induced iNOS expression and nitric oxide production. Incubation of rat islets for 3 h or human islets for 2 h with poly IC alone or poly IC + IFN-γ resulted in NF-κB nuclear translocation and degradation of the NF-κB inhibitor protein, IκB, events that are prevented by MG-132. PKR has been shown to participate in dsRNA-induced NF-κB activation in a number of cell types, including mouse embryonic fibroblasts. However, poly IC stimulated NF-κB nuclear translocation and IκB degradation to similar levels in islets isolated from mice devoid of PKR (PKR-/-) and wild-type mice (PKR+/+). Furthermore, the genetic absence of PKR did not affect dsRNA + IFN-γ-induced iNOS expression, nitric oxide production, or the inhibitory actions of these agents on glucose-stimulated insulin secretion. These results suggest that 1) NF-κB activation is required for dsRNA + IFN-γ-induced iNOS expression, 2) PKR is not required for either dsRNA-induced NF-κB activation or dsRNA + IFN-γ-induced iNOS expression by islets, and 3) PKR is not required for dsRNA + IFN-γ-induced inhibition of glucose-stimulated insulin secretion by islets.
Footnotes
-
AG, aminoguanidine; dsRNA, double-stranded RNA; HRP, horseradish peroxidase; IFN, interferon; IκB, NF-κB inhibitor protein; IKK, IκB kinase; IL-1, interleukin-1; iNOS, inducible nitric oxide synthase; JNK, c-Jun NH2-terminal kinase; KRBB, Krebs-Ringer bicarbonate buffer; MAPK, mitogen-activated protein kinase; NF-κB, nuclear factor-κB; NOS-2, nitric oxide synthase-2; PDTC, pyrrolidinedithiocarbamate; PKR, dsRNA-dependent protein kinase; poly IC, polyinosinic-polycytidylic acid; RT-PCR, reverse transcriptase-polymerase chain reaction.
-
- Accepted October 4, 2000.
- Received January 25, 2000.
- by the American Diabetes Association, Inc.














